ARTICLE | Company News
Saladax, Shanghai Fosun Pharmaceutical sales and marketing update
March 11, 2013 7:00 AM UTC
Saladax granted a division of Shanghai Fosun exclusive commercialization rights in China to Saladax's portfolio of MyCare oncology dose management assays. The portfolio includes the My5-FU diagnostic...